PetMed Express
PETS
93 hedge funds and large institutions have $35M invested in PetMed Express in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 54 reducing their positions, and 33 closing their positions.
12.41% less ownership
Funds ownership: 58.53% → 46.11% (-12%)
17% less call options, than puts
Call options by funds: $493K | Put options by funds: $597K
21% less funds holding
Funds holding: 117 → 93 (-24)
28% less capital invested
Capital invested by funds: $48.9M → $35M (-$13.9M)
72% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 54
73% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Metavasi Capital
Larchmont,
New York
|
+$811K |
| 2 |
BFG
Bleakley Financial Group
Fairfield,
New Jersey
|
+$268K |
| 3 |
D.E. Shaw & Co
New York
|
+$253K |
| 4 |
Renaissance Technologies
New York
|
+$137K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.2M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.16M |
| 3 |
Goldman Sachs
New York
|
-$1.07M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$724K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$709K |
PETS Hedge Fund Activity: Q3 2024 in Review
93 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q3 2024, worth a combined $35M — down 28% from $48.9M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of PETS and 9 opened new positions — a net loss of 24 holders — while 54 trimmed existing stakes and 15 added.
The largest buyer was Metavasi Capital, opening a new position worth an estimated $811K. The largest seller was Morgan Stanley, cutting an estimated $1.2M.
- 93 institutional investors held PetMed Express (PETS) as of Q3 2024, down from 117 in Q2 2024.
- Funds reported $35M of PetMed Express stock for Q3 2024, down 28% quarter-over-quarter.
- 9 funds opened new PetMed Express positions in Q3 2024 and 33 closed out, a net change of -24 holders.
- The largest PetMed Express buyer in Q3 2024 was Metavasi Capital, an estimated $811K added.
- The largest PetMed Express seller in Q3 2024 was Morgan Stanley, an estimated $1.2M sold.
Based on aggregated 13F filings for Q3 2024.